Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase
暂无分享,去创建一个
[1] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[2] J Sirot,et al. Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit , 1989, Journal of clinical microbiology.
[3] J. Quinn,et al. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae , 1989, Antimicrobial Agents and Chemotherapy.
[4] R. Cluzel,et al. Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins , 1988, Antimicrobial Agents and Chemotherapy.
[5] G. Gerbaud,et al. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. , 1988, Reviews of infectious diseases.
[6] W. Sougakoff,et al. Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes. , 1988, Reviews of infectious diseases.
[7] J. Carlet,et al. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. , 1988, Reviews of infectious diseases.
[8] R. Cluzel,et al. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins , 1988, Antimicrobial Agents and Chemotherapy.
[9] R. Labia,et al. Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins. , 1988, The Journal of antimicrobial chemotherapy.
[10] J. Carlet,et al. Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors , 1988, Antimicrobial Agents and Chemotherapy.
[11] R. Labia,et al. Klebsiella pneumoniae strains more resistant to ceftazidime than to other third-generation cephalosporins. , 1987, The Journal of antimicrobial chemotherapy.
[12] Patrick Legrand,et al. TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAE , 1987, The Lancet.
[13] F. Tenover,et al. Plasmid fingerprinting. A tool for bacterial strain identification and surveillance of nosocomial and community-acquired infections. , 1985, Clinics in laboratory medicine.
[14] B. Wiedemann,et al. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins , 1985, Antimicrobial Agents and Chemotherapy.
[15] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[16] H. Neu. The new beta-lactamase-stable cephalosporins. , 1982, Annals of internal medicine.
[17] A. Medeiros,et al. Characterization of the beta-lactamases of six species of Legionella , 1982, Journal of bacteriology.
[18] D. Portnoy,et al. Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis , 1981, Infection and immunity.
[19] E. Southern. Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.
[20] A. Harris,et al. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. , 1975, Journal of general microbiology.